PBYI icon

Puma Biotechnology

139 hedge funds and large institutions have $442M invested in Puma Biotechnology in 2019 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 60 increasing their positions, 31 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more ownership

Funds ownership:

less funds holding

Funds holding:

43% less first-time investments, than exits

New positions opened: 23 | Existing positions closed: 40

50% less funds holding in top 10

Funds holding in top 10: 42 (-2)

67% less capital invested

Capital invested by funds: $1.32B → $442M (-$882M)

Holders
139
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$5.05M
Puts
$2.88M
Net Calls
Net Calls Change

Top Buyers

1 +$38M
2 +$8.01M
3 +$7.72M
4
Deutsche Bank
Deutsche Bank
Germany
+$7.38M
5
Morgan Stanley
Morgan Stanley
New York
+$4.54M

Top Sellers

1 -$84.2M
2 -$34.9M
3 -$16.5M
4
O
OrbiMed
New York
-$16M
5
Federated Hermes
Federated Hermes
Pennsylvania
-$10M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$4.47M
27
$4.44M
28
$4.35M
29
$3.67M
30
$3.34M
31
$3.24M
32
$3.21M
33
$3.04M
34
$2.96M
35
$2.82M
36
$2.7M
37
$2.56M
38
$2.39M
39
$2.39M
40
$2.31M
41
$2.01M
42
$1.61M
43
$1.58M
44
$1.52M
45
$1.42M
46
$1.36M
47
$1.3M
48
$1.28M
49
$1.21M
50
$1.2M